Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CICAFAST: Biological vs Traditional Dressing for Skin Graft Donor Sites
NCT03334656Phase 2Terminated
- Sponsor
- CHU de Nantes
- Start
- May 2018
- Primary completion
- Jul 2024
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Cicafast in split-thickness skin graft donor site wound, sponsored by CHU de Nantes. Started May 2018; status: terminated.
02
Drugs
Cicafast
03
Conditions
split-thickness skin graft donor site wound
Beyond the preview
Go deeper on NCT03334656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03334656.